Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T02:59:28.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study content, indicating restricted access to the ClinicalTrials.gov record.
    Difference
    18%
    Check dated 2026-09-21T00:32:13.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page adds a 2015 U.S. NIH grant/contract acknowledgment and updates the revision tag from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T22:22:42.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added page revision v3.6.5 to replace v3.6.4, indicating a new version of the page has been published. This appears to reflect internal fixes or small tweaks rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-09T11:04:18.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, indicating an updated version of the record; this reflects administrative maintenance rather than a modification to the study details.
    Difference
    0.0%
    Check dated 2026-07-25T18:20:09.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The revision history shows a update to version v3.6.3, indicating a software/maintenance update to the page’s underlying system, with no changes to the displayed study data.
    Difference
    0.0%
    Check dated 2026-07-04T10:09:23.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.